CAL
KURA icon

Capital Advisors Ltd’s Kura Oncology KURA Stock Holding History

Capital Advisors Ltd’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
13
– – ﹤0.01% 1483
2026
Q1 		$0 Hold
13
– – ﹤0.01% 1495
2025
Q4 		$0 Hold
13
– – ﹤0.01% 1470
2025
Q3 		$0 Hold
13
– – ﹤0.01% 1471
2025
Q2 		$0 Buy
+13
New +$80 ﹤0.01% 1501

Other funds holding KURA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Capital Advisors Ltd's KURA Position: Q2 2026 in Review

Capital Advisors Ltd held its Kura Oncology (KURA) position steady in Q2 2026 at 13 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

Capital Advisors Ltd first reported a position in KURA in Q2 2025 and has held it in 5 quarters since. 25 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Capital Advisors Ltd held 13 shares of Kura Oncology worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1483 holding.
  • Capital Advisors Ltd first reported a position in Kura Oncology in Q2 2025 and has held it in 5 quarters since.
  • 25 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.